Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues	$ 4,488,932	$ 4,359,406	$ 8,544,507	$ 6,883,318
Cost of revenues	3,677,355	4,235,024	7,503,370	6,627,113
Research and development	5,796,022	3,972,127	10,554,535	7,133,453
Selling, general, and administrative	7,446,017	4,322,434	16,416,032	10,124,306
Total operating costs and expenses	16,919,394	12,529,585	34,473,937	23,884,872
Operating loss	(12,430,462)	(8,170,179)	(25,929,430)	(17,001,554)
Other income (expense):
Other income (expense), net	(185,737)	57,950	(375,288)	68,556
Interest expense	(105,906)	(65,844)	(200,062)	(109,405)
Nonoperating Income (Expense), Total	(291,643)	(7,894)	(575,350)	(40,849)
Loss before provision for income taxes and noncontrolling interests	(12,722,105)	(8,178,073)	(26,504,780)	(17,042,403)
Provision for income taxes	47,387	447,568	94,796	447,568
Net loss	(12,769,492)	(8,625,641)	(26,599,576)	(17,489,971)
Less - loss attributable to noncontrolling interests	(164,474)	(50,282)	(312,502)	(114,036)
Net loss attributable to NeoStem, Inc. common stockholders	$ (12,605,018)	$ (8,575,359)	$ (26,287,074)	$ (17,375,935)
Basic and diluted loss per share attributable to NeoStem, Inc. common stockholders	$ (0.40)	$ (0.46)	$ (0.88)	$ (0.99)
Weighted average common shares outstanding	31,739,417	18,503,236	29,940,128	17,606,051